Tag Archives: ER protac

04Jun/23

PROTAC is Moving Towards Clinical Application of Oncology—II

June 4, 2023protac reviewsAR PROTAC, BTK PROTAC, ER protacbiolabs

Preclinical evidence of PROTAC The breakthrough in PROTAC’s design paves the way for its early clinical trials. According to statistics, as of January 8, 2023, 18 kinds of PROTAC were conducting phaseRead More…

14Sep/21

A strategic partnership worthy of 2.45 billion dollars reached between Pfizer and Arvinas to develop PROTAC protein degradants against ER+ breast cancer!

September 14, 2021PROTAC NewsER protac, protac against breast cancerbiolabs

Recently, Pfizer and Arvinas announced a partnership to develop and commercialize ARV-471, an oral PROTAC estrogen receptor protein degrader under development. Estrogen receptor (ER) is a well-known disease driver in most breastRead More…

PROTAC Research
PROTAC News